ROCHESTER MEDICAL CORPORATION - FORM 10-K - EX-21 - SUBSIDIARIES OF THE COMPANY - December 9, 2011

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ROCHESTER MEDICAL CORPORATIONFinancial_Report.xls
10-K - FORM 10-K - ROCHESTER MEDICAL CORPORATIONd255969d10k.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(B) - ROCHESTER MEDICAL CORPORATIONd255969dex321.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(B) - ROCHESTER MEDICAL CORPORATIONd255969dex322.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) - ROCHESTER MEDICAL CORPORATIONd255969dex311.htm
EX-23.1 - CONSENT OF GRANT THORNTON LLP - ROCHESTER MEDICAL CORPORATIONd255969dex231.htm
EX-24 - POWER OF ATTORNEY - ROCHESTER MEDICAL CORPORATIONd255969dex24.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) - ROCHESTER MEDICAL CORPORATIONd255969dex312.htm

Exhibit 21

SUBSIDIARIES OF ROCHESTER MEDICAL CORPORATION

The Company’s consolidated subsidiaries are shown below, together with the percentage of voting securities owned and the state or jurisdiction of each subsidiary:

 

Subsidiaries

    Percentage of
Outstanding Voting
Securities Owned		  

Rochester Medical Ltd.

      100 % 

(United Kingdom)

   

Laprolan B.V.

      100 % 

(The Netherlands)

   

ROCHESTER MEDICAL CORPORATION Reports